Evaluation of therapeutic efficacy with CytoSorter^® circulating tumor cell–capture system in patients with locally advanced head and neck squamous cell carcinoma

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34. doi:10.3322/caac.2155130620402
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92(9):709–720. doi:10.1093/jnci/92.9.70910793107
   PubMed Web of Science ®Google Scholar
• Kumar B, Cordell KG, Lee JS, et al. EGFR, p16, HPV titer, bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol. 2008;26(19):3128–3137. doi:10.1200/JCO.2007.12.766218474878
   PubMed Web of Science ®Google Scholar
• Mansouri S, Hesari PM, Naghavi-Al-Hosseini F, Majidzadeh-A K, Farahmand L. The prognostic value of circulating tumor cells in primary breast cancer prior to any systematic therapy: a systematic review. Curr Stem Cell Res Ther. 2019. doi:10.2174/1574888X14666190306103759
   PubMed Web of Science ®Google Scholar
• Wang L, Zhou S, Zhang W, et al. Circulating tumor cells as an independent prognostic factor in advanced colorectal cancer: a retrospective study in 121 patients. Int J Colorectal Dis. 2019;34(4):589–597. doi:10.1007/s00384-018-03223-930627849
   PubMed Web of Science ®Google Scholar
• Syrigos K, Fiste O, Charpidou A, Grapsa D. Circulating tumor cells count as a predictor of survival in lung cancer. Crit Rev Oncol Hematol. 2018;125:60–68. doi:10.1016/j.critrevonc.2018.03.00429650278
   PubMed Web of Science ®Google Scholar
• Josefsson A, Linder A, Flondell Site D, et al. Circulating tumor cells as a marker for progression-free survival in metastatic castration-naïve prostate cancer. Prostate. 2017;77(8):849–858. doi:10.1002/pros.2332528295408
   PubMed Web of Science ®Google Scholar
• Jiang T, Zhao J, Zhao C, et al. Dynamic monitoring and predictive value of circulating tumor cells in EGFR-mutated advanced non-small-cell lung cancer patients treated with first-line EGFR tyrosine kinase inhibitors. Clin Lung Cancer. 2019;20(2):124–133. doi:10.1016/j.cllc.2018.11.01430587399
   PubMed Web of Science ®Google Scholar
• Wei T, Zhang X, Zhang Q, et al. Vimentin-positive circulating tumor cells as a biomarker for diagnosis and treatment monitoring in patients with pancreatic cancer. Cancer Lett. 2019;452:237–243. doi:10.1016/j.canlet.2019.03.00930905814
   PubMed Web of Science ®Google Scholar
• Sparano J, O’Neill A, Alpaugh K, et al. Association of circulating tumor cells with late recurrence of estrogen receptor-positive breast cancer: a secondary analysis of a randomized clinical trial. JAMA Oncol. 2018;4(12):1700–1706. doi:10.1001/jamaoncol.2018.257430054636
   PubMed Web of Science ®Google Scholar
• Goodman CR, Seagle BL, Friedl TWP, et al. Association of circulating tumor cell status with benefit of radiotherapy and survival in early-stage breast cancer. JAMA Oncol. 2018;4(8):e180163. doi:10.1001/jamaoncol.2017.447329800954
   PubMed Web of Science ®Google Scholar
• Yue C, Jiang Y, Li P, et al. Dynamic change of PD-L1 expression on circulating tumor cells in advanced solid tumor patients undergoing PD-1 blockade therapy. Oncoimmunology. 2018;7(7):e1438111. doi:10.1080/2162402X.2018.149085429900038
   PubMed Web of Science ®Google Scholar
• Shen Z, Wu A, Chen X. Current detection technologies for circulating tumor cells. Chem Soc Rev. 2017;46(8):2038–2056. doi:10.1039/c6cs00803h28393954
   PubMed Web of Science ®Google Scholar
• Nichols AC, Lowes LE, Szeto CC, et al. Detection of circulating tumor cells in advanced head and neck cancer using the cell search system. Head Neck. 2012;34(10):1440–1444. doi:10.1002/hed.2194122076949
   PubMed Web of Science ®Google Scholar
• Bozec A, Ilie M, Dassonville O, et al. Significance of circulating tumor cell detection using the CellSearch system in patients with locally advanced head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2013;270(10):2745–2749. doi:10.1007/s00405-013-2399-y23430081
   PubMed Web of Science ®Google Scholar
• He S, Li P, He S, et al. Detection of circulating tumour cells with the CellSearch system in patients with advanced-stage head and neck cancer: preliminary results. J Laryngol Otol. 2013;127(8):788–793. doi:10.1017/S002221511300141223835309
   PubMed Web of Science ®Google Scholar
• Grisanti S, Almici C, Consoli F, et al. Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance. PLoS One. 2014;9(8):e103918. doi:10.1371/journal.pone.010391825105871
   PubMed Web of Science ®Google Scholar
• Cabel L, Proudhon C, Gortais H, et al. Circulating tumor cells: clinical validity and utility. Int J Clin Oncol. 2017;22(3):421–430. doi:10.1007/s10147-017-1105-228238187
   PubMed Web of Science ®Google Scholar
• Massagué J, Obenauf AC. Metastatic colonization by circulating tumour cells. Nature. 2016;529(7586):298–306. doi:10.1038/nature1703826791720
   PubMed Web of Science ®Google Scholar
• Micalizzi DS, Maheswaran S, Haber DA. A conduit to metastasis: circulating tumor cell biology. Genes Dev. 2017;31(18):1827–1840. doi:10.1101/gad.305805.11729051388
   PubMed Web of Science ®Google Scholar
• Budd GT, Cristofanilli M, Ellis MJ, et al. Circulating tumor cells versus imaging–predicting overall survival in metastatic breast cancer. Clin Cancer Res. 2006;12(21):6403–6409. doi:10.1158/1078-0432.CCR-05-176917085652
   PubMed Web of Science ®Google Scholar
• Wu XL, Tu Q, Faure G, Gallet P, Kohler C, Bittencourt MDC. Diagnostic and prognostic value of circulating tumor cells in head and neck squamous cell carcinoma: a systematic review and meta-analysis. Sci Rep. 2016;6:20210. doi:10.1038/srep2021026831813
   PubMed Web of Science ®Google Scholar
• Zou D, Cui D. Advances in isolation and detection of circulating tumor cells based on microfluidics. Cancer Biol Med. 2018;15(4):335–353. doi:10.20892/j.issn.2095-3941.2018.025630766747
   PubMed Web of Science ®Google Scholar
• McMullen KP, Chalmers JJ, Lang JC, Kumar P, Jatana KR. Circulating tumor cells in head and neck cancer: a review. World J Otorhinolaryngol Head Neck Surg. 2016;2(2):109–116. doi:10.1016/j.wjorl.2016.05.00329204555
   PubMedGoogle Scholar
• Tinhofer I, Konschak R, Stromberger C, et al. Detection of circulating tumor cells for prediction of recurrence after adjuvant chemoradiation in locally advanced squamous cell carcinoma of the head and neck. Ann Oncol. 2014;25(10):2042–2047. doi:10.1093/annonc/mdu27125057171
   PubMed Web of Science ®Google Scholar
• Valiathan R, Ashman M, Asthana D. Effects of ageing on the immune system: infants to elderly. Scand J Immunol. 2016;83(4):255–266. doi:10.1111/sji.1241326808160
   PubMed Web of Science ®Google Scholar
• Que Z, Luo B, Zhou Z, et al. Establishment and characterization of a patient-derived circulating lung tumor cell line in vitro and in vivo. Cancer Cell Int. 2019;19:21. doi:10.1186/s12935-019-0735-z30718976
   PubMed Web of Science ®Google Scholar
• Lowes LE, Goodale D, Xia Y, et al. Epithelial to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer. Oncotarget. 2016;7(46):76125–76139. doi:10.18632/oncotarget.1268227764810
   PubMedGoogle Scholar
• Satelli A, Mitra A, Brownlee Z, et al. Epithelial-mesenchymal transitioned circulating tumor cells capture for detecting tumor progression. Clin Cancer Res. 2015;21(4):899–906. doi:10.1158/1078-0432.CCR-14-089425516888
   PubMed Web of Science ®Google Scholar
• Satelli A, Brownlee Z, Mitra A, Meng QH, Li S. Circulating tumor cell enumeration with a combination of epithelial cell adhesion molecule- and cell-surface vimentin-based methods for monitoring breast cancer therapeutic response. Clin Chem. 2015;61(1):259–266. doi:10.1373/clinchem.2014.22812225336717
   PubMed Web of Science ®Google Scholar
• Winter SC, Stephenson SA, Subramaniam SK, et al. Long term survival following the detection of circulating tumour cells in head and neck squamous cell carcinoma. BMC Cancer. 2009;9:424. doi:10.1186/1471-2407-9-42419961621
   PubMed Web of Science ®Google Scholar
• Jatana KR, Lang JC, Chalmers JJ. Identification of circulating tumor cells: a prognostic marker in squamous cell carcinoma of the head and neck? Future Oncol. 2011;7(4):481–484. doi:10.2217/fon.11.1921463135
   PubMed Web of Science ®Google Scholar
• Hristozova T, Konschak R, Stromberger C, et al. The presence of circulating tumor cells (CTCs) correlates with lymph node metastasis in nonresectable squamous cell carcinoma of the head and neck region (SCCHN). Ann Oncol. 2011;22(8):1878–1885. doi:10.1093/annonc/mdr13021525401
   PubMed Web of Science ®Google Scholar
• Buglione M, Grisanti S, Almici C, et al. Circulating tumour cells in locally advanced head and neck cancer: preliminary report about their possible role in predicting response to non-surgical treatment and survival. Eur J Cancer. 2012;48(16):3019–3026. doi:10.1016/j.ejca.2012.05.00722682019
   PubMed Web of Science ®Google Scholar
• Harris AT, Derbyshire S, Wilson J, et al. Circulating and disseminated tumour cells in head and neck cancer. J Laryngol Otol. 2015;129(9):826–830. doi:10.1017/S002221511500178426174011
   PubMed Web of Science ®Google Scholar
• Wang HM, Wu MH, Chang PH, et al. The change in circulating tumor cells before and during concurrent chemoradiotherapy is associated with survival in patients with locally advanced head and neck cancer. Head Neck. 2019. doi:10.1002/hed.25744
   Web of Science ®Google Scholar
• Bayarri-Lara C, Ortega FG, de Guevara ACL, et al. Circulating tumor cells identify early recurrence in patients with non-small cell lung cancer undergoing radical resection. PLoS One. 2016;11(2):e0148659. doi:10.1371/journal.pone.014865926913536
   PubMed Web of Science ®Google Scholar
• Von Felden J, Schulze K, Krech T, et al. Circulating tumor cells as liquid biomarker for high HCC recurrence risk after curative liver resection. Oncotarget. 2017;8(52):89978–89987. doi:10.18632/oncotarget.2120829163804
   PubMedGoogle Scholar